Clinical decisions. Management of incidental hepatitis C virus infection

N Engl J Med. 2009 Apr 30;360(18):1902-6. doi: 10.1056/NEJMclde0900131.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Alanine Transaminase / blood
  • Antiviral Agents / therapeutic use
  • Aspartate Aminotransferases / blood
  • Biopsy
  • Female
  • Genotype
  • Hepacivirus / genetics
  • Hepacivirus / immunology
  • Hepatitis C / therapy*
  • Hepatitis C Antibodies / blood
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use
  • Liver / pathology
  • Polyethylene Glycols / therapeutic use
  • Recombinant Proteins
  • Ribavirin / therapeutic use

Substances

  • Antiviral Agents
  • Hepatitis C Antibodies
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • Aspartate Aminotransferases
  • Alanine Transaminase
  • peginterferon alfa-2a